General neurologist · Kyoto University Hospital · Japan (JP) · Neurology
Data minimisation
Cadence target for Tier 3: 1 per year (assumption)
3 of 1 expected engagements
No insights captured from engagements with this stakeholder.
All engagements including drafts, newest first
| Date | Type | Format | MSL | Product | Topics | Insights | Flags | Status | |
|---|---|---|---|---|---|---|---|---|---|
| 03 Sept 2026 | Payer / HTA meeting | In person | James Whitfield | Lumeva | Dosing in hepatic impairmentReal-world persistence+1 | 0 | — | Reviewed | ENG-0210 |
| 24 Jul 2026 | Scientific exchange | Virtual | James Whitfield | Lumeva | Chronic migraine dataSwitching between CGRP agents+1 | 0 | MI request | Reviewed | ENG-0214 |
| 17 Jun 2026 | Congress meeting | In person | James Whitfield | Lumeva | Switching between CGRP agents | 0 | — | Reviewed | ENG-0197 |
| 17 Feb 2026 | Scientific exchange | In person | James Whitfield | Lumeva | Dosing in hepatic impairmentChronic migraine data | 0 | — | Reviewed | ENG-0183 |
03 Sept 2026
Dosing in hepatic impairment, Real-world persistence, Drug interactions
24 Jul 2026
Chronic migraine data, Switching between CGRP agents, Dosing in hepatic impairment
17 Jun 2026
Switching between CGRP agents
17 Feb 2026
Dosing in hepatic impairment, Chronic migraine data
Kyoto University Hospital
Pathologist
Pathologist
Radiation oncologist
Radiation oncologist
General neurologist
General neurologist
Primary care physician